| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |